Reify Health

Reify Health has raised $478M in funding through multiple rounds: $30M Series B (Aug 12, 2020), $220M Series C (Aug 10, 2021), and $220M Series D (Apr 21, 2022). Key investors include Dragoneer Investment Group, Altimeter Capital, Coatue, Battery Ventures, and Iconiq Capital. Reify Health, headquartered in Boston, United States, provides AI-enhanced mobile health solutions for clinical trials, including patient recruitment, engagement, and custom mobile health algorithms, enabling researchers and scientists to accelerate trial processes and improve patient outcomes.